Integral Diagnostics Ltd (ASX:IDX)
A$ 2.92 0.05 (1.74%) Market Cap: 1.07 Bil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 2.22 GF Score: 85/100

Half Year 2022 Integral Diagnostics Ltd Earnings Call Transcript

Feb 22, 2022 / 11:00PM GMT
Release Date Price: A$3.86 (-0.51%)
Operator

Thank you for standing by, and welcome to the Integral Diagnostics 1H FY '20 Results Call. (Operator Instructions) I would now like to hand the conference over to Dr. Ian Kadish, CEO and Managing Director. Please go ahead.

Ian Kadish
Integral Diagnostics Limited - CEO, MD & Director

Thank you very much, Lexy. My name is Ian Kadish. I'm the Chief Executive Officer and Managing Director of Integral Diagnostics. I'm joined this morning by Craig White. Craig is our Chief Financial Officer. It's our privilege this morning to be talking to you about our H1 FY '22 results. And we also have the privilege of discussing with you an exciting acquisition that we announced this morning, together with its associated capital raise. We plan to spend 15 to 20 minutes on the H1 results, given that these results were in the main release on the Australian Stock Exchange on 27th of January when we posted a market update and then to spend about 20 minutes discussing the acquisition and associated capital raise and then have 20 minutes at the end for questions and answers.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot